APA (7th ed.) Citation

R, R., IC, H., P, R., RA, H., A, F., J, W., . . . CJ, S. (2022). Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors. Nature communications, 13(1), 4785. https://doi.org/10.1038/s41467-022-32436-4

Chicago Style (17th ed.) Citation

R, Reinbold, et al. "Resistance to the Isocitrate Dehydrogenase 1 Mutant Inhibitor Ivosidenib Can Be Overcome by Alternative Dimer-interface Binding Inhibitors." Nature Communications 13, no. 1 (2022): 4785. https://doi.org/10.1038/s41467-022-32436-4.

MLA (9th ed.) Citation

R, Reinbold, et al. "Resistance to the Isocitrate Dehydrogenase 1 Mutant Inhibitor Ivosidenib Can Be Overcome by Alternative Dimer-interface Binding Inhibitors." Nature Communications, vol. 13, no. 1, 2022, p. 4785, https://doi.org/10.1038/s41467-022-32436-4.